Novo Nordisk CEO Has No Plans for Big Acquisitions

Danish Insulin-Maker Looks Set to Sit Out Deal-Making Frenzy That has Convulsed The Industry

LONDON—The chief executive of insulin maker Novo Nordisk A/S said he has no plans to pursue any big acquisitions, suggesting his company will be sitting out the frenzy of deal-making that has convulsed the global pharmaceutical industry this year.

Denmark-based Novo Nordisk is controlled by a foundation that makes it all but impossible for it to be acquired by another company. But it is among a handful of pharmaceutical companies large enough to be on the hunt for acquisitions itself. In the recent past, Novo Nordisk...